Sciety user Paul Hassan Ilegbusi

Sciety handle @esupofo1973

Review Commons is a platform for high-quality journal-independent peer-review in the life sciences.

eLife reviews preprints in the life sciences and medicine.

Arcadia Science is a science company that shares open research publications and requests community feedback. To contribute to the ecosystem of open review, our scientists make public comments on public products. Our scientists comment modularly, annotating preprints with specific comments on the areas that best align with their expertise.

PREreview's mission is to bring more diversity to scholarly peer review by supporting and empowering community of researchers, particularly those at early stages of their career (ECRs) to review preprints.

RR\ID (Rapid Reviews\Infectious Diseases) is an open-access overlay journal that accelerates peer review of important infectious disease-related research preprints.

GigaScience is an open access, open data, open peer-review journal focusing on ‘big data’ research from the life and biomedical sciences.

PeerJ is an open access publisher of 7 peer-reviewed journals, and an editorial community of over 2000 Academic Editors and Advisors, and tens of thousands of authors and reviewers.

PeerRef is a journal-independent open peer review platform for all research.

We promote the productive use of preprints for research dissemination and transparent peer review and feedback on all research outputs.

The Automated Screening Working Groups is a group of software engineers and biologists passionate about improving scientific manuscripts on a large scale. Our members have created tools that check for common problems in scientific manuscripts, including information needed to improve transparency and reproducibility. We have combined our tools into a single pipeline, called ScreenIT. We're currently using our tools to screen COVID preprints.

The 2019 Novel Coronavirus Research Compendium (NCRC) is a centralized, publicly available resource that rapidly curates and reviews the emerging scientific evidence about SARS-CoV-2 and COVID-19. Our goal is to provide accurate, relevant information for global public health action by clinicians, public health practitioners, and policy makers.